Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Genetic and Molecular Underpinning of Nicotine Addiction for the Development of New Therapeutic Strategies

NCT06471387 is registered in ClinicalTrials.gov with University of Cyprus as lead sponsor.

NCT NCT06471387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06471387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Genetic and Molecular Underpinning of Nicotine Addiction for the Development of New Therapeutic Strategies
Lead sponsor
University of Cyprus
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2023
Completion date
October 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epigenetics, genetic epidemiology, molecular biology, nicotine addiction, smoking cessation, smoking cessation intervention